Literature DB >> 28161349

Obesity as a Risk Factor for Unfavorable Disease in Men with Low Risk Prostate Cancer and its Relationship with Anatomical Location of Tumor.

In Gab Jeong1, Sangjun Yoo1, Chunwoo Lee1, Myong Kim1, Dalsan You1, Cheryn Song1, Sungchan Park1, Jun Hyuk Hong1, Hanjong Ahn1, Choung-Soo Kim2.   

Abstract

PURPOSE: We investigated the influence of obesity on unfavorable disease in men with low risk prostate cancer eligible for active surveillance and verified the underlying relationship with tumor location.
MATERIALS AND METHODS: We analyzed the records of 890 patients with biopsy Gleason score 6 who underwent radical prostatectomy for prostate cancer via multicore (12 or more) biopsy at our institution. Unfavorable disease was defined as primary Gleason pattern 4 or greater, or pathological stage T3 or greater. Multivariate logistic regression analysis was performed to identify factors associated with unfavorable disease. The association of unfavorable disease with anatomical location of the index tumor was assessed.
RESULTS: Overall 216 (24.3%), 544 (61.1%) and 130 men (14.6%) had a body mass index of less than 23 (normal), 23 to 27.5 (overweight) and 27.5 kg/m2 or greater (obese), respectively, according to established cutoff points for Asian men. Multivariate analysis showed that age, prostate volume and body mass index were independent factors for predicting unfavorable disease regardless of the various active surveillance criteria used. For Johns Hopkins Hospital criteria the risk of unfavorable disease was higher in obese patients than in normal weight patients (OR 3.30, p = 0.022). Unfavorable disease was more frequent in cases of transition zone cancer than nontransition zone cancer across all criteria for active surveillance (all p <0.01). Among men fulfilling Johns Hopkins Hospital criteria the proportion of transition zone cancer was 4.2% for normal weight, 11.6% for overweight and 16.7% for obesity, respectively (p = 0.022).
CONCLUSIONS: Obese men with low risk prostate cancer who are eligible for active surveillance are at higher risk for unfavorable pathological features. Obese men more frequently had transition zone cancer, which was associated with unfavorable pathology findings in those with very low risk prostate cancer.
Copyright © 2017 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  obesity; prostatectomy; prostatic neoplasms; risk factors; watchful waiting

Mesh:

Year:  2017        PMID: 28161349     DOI: 10.1016/j.juro.2017.01.073

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Effect of intraoperative mannitol administration on acute kidney injury after robot-assisted laparoscopic radical prostatectomy: A propensity score matching analysis.

Authors:  Yu-Gyeong Kong; Ji Hyun Park; Jun-Young Park; Jihion Yu; Joonho Lee; Se-Ung Park; In Gab Jeong; Jai-Hyun Hwang; Hee Yeong Kim; Young-Kug Kim
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

2.  Cause of Mortality after Radical Prostatectomy and the Impact of Comorbidity in Men with Prostate Cancer: A Multi-institutional Study in Korea.

Authors:  Sahyun Pak; Dalsan You; In Gab Jeong; Dong-Eun Lee; Sung Han Kim; Jae Young Joung; Kang-Hyun Lee; Jun Hyuk Hong; Choung-Soo Kim; Hanjong Ahn
Journal:  Cancer Res Treat       Date:  2020-07-03       Impact factor: 4.679

3.  Association between prostate cancer characteristics and BRCA1/2-associated family cancer history in a Japanese cohort.

Authors:  Yudai Ishiyama; Masaki Shimbo; Junpei Iizuka; Gautam Deshpande; Kazunari Tanabe; Kazunori Hattori
Journal:  PLoS One       Date:  2020-12-22       Impact factor: 3.240

4.  Incidence and Risk Factors of Pulmonary Complications after Robot-Assisted Laparoscopic Prostatectomy: A Retrospective Observational Analysis of 2208 Patients at a Large Single Center.

Authors:  Jihion Yu; Jun-Young Park; Doo-Hwan Kim; Sungwon Kim; Jai-Hyun Hwang; Hyungseok Seo; Young-Kug Kim
Journal:  J Clin Med       Date:  2019-09-20       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.